Intech Biopharm (6461.TWO) Stock Price

Intech Biopharm Price

CLOSED
28.00
​
Market closed

Over the last 12 years Intech Biopharm grew revenue by 25.5% annually, reaching 107.53 M TWD. For Intech Biopharm, the net margin of -361.8% is up versus -775.7% a few years ago.

Intech Biopharm stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intech Biopharm business model & stock analysis

Intech Biopharm Ltd is a pharmaceutical company based in Taipei City, Taiwan. The company went public on July 15, 2014, with the ticker symbol 6461.TWO and ISIN TW0006461007. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. Intech Biopharm focuses on developing drugs for obstructive airway diseases, including bronchial asthma and chronic obstructive pulmonary disease. The company's primary products are respiratory drugs, notably the Duasma hexafluoroacetone (HFA) metered-dose inhalers (MDIs) and the Synvent HFA MDIs. These products are distributed both domestically within Taiwan and internationally. The company maintains a website at http://www.intechbiopharm.com/ for further information. Intech Biopharm Ltd is engaged in the research, development, and distribution of pharmaceutical products targeting respiratory conditions, with a focus on innovative inhaler technologies. The firm's operations are centered on addressing unmet medical needs in respiratory care through its specialized drug formulations.

Frequently asked questions about Intech Biopharm

Converted at the current exchange rate, the Intech Biopharm share trades at 0.77 EUR (28.00 TWD).

The revenue cannot currently be calculated for Intech Biopharm.

The profit cannot currently be calculated for Intech Biopharm.

The P/E ratio cannot be calculated for Intech Biopharm at the moment.

The P/S cannot be calculated for Intech Biopharm currently.

The Eulerpool Quality Score for Intech Biopharm is 4/10.

The ISIN of Intech Biopharm is TW0006461007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Intech Biopharm is 6461.TWO. The ticker symbol is used to trade Intech Biopharm shares on the stock exchange.

Fair ValueTerminal
23.80 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jul 15, 2014
ISIN
TW0006461007
Cusip
Y4R85U107
Market capitalization
4.59 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.56 %
Last updated Oct 20, 2026, 7:25 AM

Intech Biopharm Peer Group

Intech Biopharm FIGI

6461:TT (Taipei Stock Exchange) · BBG006S3TQF4